Reducing cross-held shares and reviewing the rationale for holdings
First written in FY2019. 5 of 6 entries say "Advanced", first in FY2023. Latest entry: FY2026.
- FY2026AdvancedAnnual report
「In fiscal 2025, the company completed the reduction of 2 of its 11 listed stock holdings, leaving 9 listed holdings as of the end of the fiscal year ending March 2026.」
Based on its policy of reducing cross-shareholdings, the company reduced 2 holdings in fiscal 2025, decreasing its listed holdings from 11 to 9. - FY2025-H1AdvancedAnnual report
「Special gains and losses improved by ¥2,720 million from the same period of the previous year, mainly because gains on sales of investment securities increased as the company proceeded with reducing its cross-shareholdings, and because it recognized a gain on the exchange of shares in an affiliated company in connection with the reorganization of its polyolefin film business.」
The company proceeded with reducing its cross-shareholdings, increasing gains on sales of investment securities from ¥609 million in the same period of the previous year to ¥1,141 million. Additional sales were made under the reduction policy. - FY2023AdvancedAnnual report
「During fiscal 2022, the company sold 1 listed stock holding, leaving 20 listed holdings.」
Based on its policy of reducing cross-shareholdings, the company sold 1 listed stock holding in fiscal 2022, bringing the number of holdings to 20. It has also continued its policy of having the Board of Directors verify the comparison between the cost of capital and benefits. - FY2019First statedAnnual report
「Listed shares held for purposes other than pure investment will be reduced as far as possible from the perspective of achieving efficient corporate management. In addition, the Board of Directors verifies their economic rationale each year by comparing the risk-adjusted cost of capital with the benefits, and confirms whether continued holdings are appropriate in light of future prospects.」
The company identified for the first time as a topic its policy of reducing cross-shareholdings as far as possible and verifying each year at Board of Directors meetings whether continued holdings are rational based on the cost of capital, benefits and future prospects.